21Jun/13

Novartis heart failure drug gets FDA incentives – Yahoo! New Zealand News


Economic Times

Novartis heart failure drug gets FDA incentives
Yahoo! New Zealand News
NEW YORK (AP) — Novartis AG said Friday its drug serelaxin, a treatment for acute heart failure, received breakthrough therapy status from the Food and Drug Administration. The drug is intended to treat symptoms of acute heart failure episodes
US FDA deems Novartis’ heart failure candidate a ‘breakthrough’PMLiVE
FDA grants Breakthrough Therapy designation to Novartis’ serelaxin (RLX030 FierceBiotech
Novartis Heart-Failure Drug Wins ‘Breakthrough’ Status at FDABusinessweek
TheHeart.Org –DailyFinance
all 13 news articles »
21Jun/13

FDA grants Breakthrough Therapy designation to Novartis' serelaxin (RLX030 … – FierceBiotech


Economic Times

FDA grants Breakthrough Therapy designation to Novartis’ serelaxin (RLX030
FierceBiotech
Basel, June 21, 2013 – Novartis announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation status to RLX030 (serelaxin), an investigational treatment for patients with acute heart failure (AHF). The FDA 
Novartis heart failure drug gets FDA incentivesBusinessweek
US FDA deems Novartis’ heart failure candidate a ‘breakthrough’PMLiVE
Serelaxin, Experimental Heart Drug From Norvartis, Obtains FDA Breakthrough Medical Daily
Fox News –Bloomberg
all 9 news articles »
21Jun/13

Indonesian fires worsen, Singapore smog sets record – Times of India


Times of India

Indonesian fires worsen, Singapore smog sets record
Times of India
Hospitals in Dumai and Bengkalis in Indonesia’s Riau province recorded increases in cases of asthma, lung, eye and skin problems, said health official Arifin Zainal. Free face masks were being distributed and authorities advised residents to stay
Dangerous Smog, Haze Smothers SingaporeAccuWeather.com

all 439 news articles »